Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy
HIGHLIGHTS who: Y. Gu from the Bristol Medical School, Translational Health Sciences, University of Bristol, Upper Maudlin Street, Bristol , […]